S025 JAK Inhibitors: A New Frontier in Dermatology
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Janus kinase (JAK) inhibitors are a new class of medicine in dermatology with unique ability to treat a broad range of inflammatory skin diseases. The application of JAK inhibitors to common dermatologic diseases will be presented, including the results of clinical trials and case series. The safety profile of JAK inhibitors will be discussed in detail. The audience for this session will be dermatologists who care for patients with alopecia areata, vitiligo, atopic dermatitis, psoriasis, granuloma annulare and sarcoidosis, lupus and dermatomyositis, and hidradenitis suppurativa. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuous Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org.
LEARNING OBJECTIVES
Identify and describe a new class of medications in dermatology.
Utilize JAK inhibitors for the treatment of alopecia areata, atopic dermatitis, dermatomyositis, granuloma annulare and sarcoidosis, hidradenitis suppurativa, lichen planus, lupus, pruritus, psoriasis, and vitiligo.
Summarize the safety profile of JAK inhibitors.
SCHEDULE
5:00 PM
Clinical Impact of the JAK-STAT Pathway
Brett Andrew King, MD, PhD, FAAD
5:10 PM
JAK Inhibitors for Vitiligo
Khaled Ezzedine, MD
5:25 PM
JAK Inhibitors for Lupus, Dermatomyositis, and SAVI
Ruth Ann Vleugels, MPH, MD, MBA, FAAD
5:40 PM
Q&A
Khaled Ezzedine, MD, Ruth Ann Vleugels, MPH, MD, MBA, FAAD
5:50 PM
JAK Inhibitors for Sarcoidosis and Granuloma Annulare
William Damsky, PhD, MD, FAAD
6:05 PM
JAK Inhibitors for Alopecia Areata
Brittany Gareth Craiglow, MD, FAAD
6:20 PM
Q&A
Brittany Gareth Craiglow, MD, FAAD, William Damsky, PhD, MD, FAAD
6:30 PM
JAK Inhibitors for Psoriasis
Melinda Gooderham, MD, FAAD
6:45 PM
JAK Inhibitors for Lichen Planus, Hidradenitis Suppurativa, and Pyoderma Gangrenosum
Tiffany Mayo, MD, FAAD
7:00 PM
Q&A
Melinda Gooderham, MD, FAAD, Tiffany Mayo, MD, FAAD
7:10 PM
JAK Inhibitors for Atopic Dermatitis and Prurigo Nodularis
Shawn Kwatra, MD, FAAD
7:30 PM
Understanding the Safety Profile of JAK Inhibitors
Brett Andrew King, MD, PhD, FAAD
7:50 PM
Q&A
Brett Andrew King, MD, PhD, FAAD, Shawn Kwatra, MD, FAAD
SPEAKERS
Brittany Gareth Craiglow, MD, FAAD
William Damsky, PhD, MD, FAAD
Khaled Ezzedine, MD
Melinda Gooderham, MD, FAAD
Brett Andrew King, MD, PhD, FAAD
Shawn Kwatra, MD, FAAD
Tiffany Mayo, MD, FAAD
Ruth Ann Vleugels, MPH, MD, MBA, FAAD
SPEAKER DISCLOSURES
Brittany Gareth Craiglow, MD, FAAD
AbbVie – Speaker(Honoraria); Concert Pharmaceuticals – Consultant(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria); EltaMD – Other(Honoraria); Incyte Corporation – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Investigator(No Compensation Received), Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Fees), Speaker(Honoraria); Roivant Sciences – Consultant(Fees); Sanofi Genzyme – Speaker(Honoraria);
William Damsky, PhD, MD, FAAD
AbbVie – Investigator(Fees); Advanced Cell Diagnostics, Inc. – Investigator(Equipment); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Bristol – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); CSL Behring – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Consultant(Fees); Epiarx Diagnostics – Consultant (1099 relationship)(Fees); Fresenius Kabi – Consultant (1099 relationship)(Fees); Incite – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Fees), Investigator(Grants/Research Funding); MilliporeSigma – Other(Patent royalties or other compensation for Intellectual Property Rights); Pfizer Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Priovant Therapeutics – Consultant (1099 relationship)(Fees); Sanofi – Consultant (1099 relationship)(Fees); TWi Biote – Consultant (1099 relationship)(Fees); TWi Biotechnology, Inc. – Consultant(Fees), Consultant (1099 relationship)(Fees), Investigator(Fees);
Khaled Ezzedine, MD
AbbVie – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees); Pierre Fabre Dermatologie – Speaker(Honoraria);
Melinda Gooderham, MD, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Acelyrin – Investigator(Grants/Research Funding); Amgen – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); AnaptysBio – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Aristea Therapeutics – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Bausch Health – Consultant(Honoraria), Investigator(Grants/Research Funding); Boehringer Ingelheim – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Cara Therapeutics – Investigator(Grants/Research Funding); Celgene Corporation – Investigator(Grants/Research Funding), Speaker(Honoraria); Dermavant Sciences – Investigator(Grants/Research Funding); Dermira – Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Galderma Laboratories, LP – Investigator(Grants/Research Funding), Speaker(Honoraria); Incyte – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Inmagene Biopharmaceuticals – Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc. – Speaker(Honoraria); Medimmune – Investigator(Grants/Research Funding); Meiji Seika Pharma Co., Ltd – Investigator(Grants/Research Funding); Moonlake – Investigator(Grants/Research Funding); Nimbus Therapeutics – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Regeneron – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Reistone Biopharma – Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Honoraria), Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); Tarsus – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Ventyx Biosciences – Investigator(Grants/Research Funding);
Brett Andrew King, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); AnaptysBio – Consultant(Fees), Investigator(Fees); Arena Pharmaceuticals – Consultant(Fees), Investigator(Fees); ASLAN Pharmaceuticals – Consultant (1099 relationship)(Fees), Investigator(Fees); BiologicsMD, Inc. – Consultant(Stock Options); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees); Concert Pharmaceuticals – Consultant(Fees), Investigator(Fees); Eli Lilly and Company – Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Equillium, Inc. – Consultant(Fees); Horizon Pharma, Inc. – Consultant(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees), Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Fees); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Q32 Bio Inc. – Consultant (1099 relationship)(Fees), Investigator(Fees); Regeneron – Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); TWi Biotechnology, Inc. – Consultant(Fees);
Shawn Kwatra, MD, FAAD
AbbVie – Consultant(Honoraria); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); ASLAN Pharmaceuticals – Consultant(Honoraria); Cara Therapeutics – Advisory Board(Honoraria); Castle Biosciences, Inc – Consultant(Honoraria); Celldex – Consultant(Honoraria); Galderma – Investigator(Grants/Research Funding); Galderma USA – Consultant(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Johnson and Johnson – Advisory Board(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Tiffany Mayo, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria); Acelyrin – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria), Investigator(Grants/Research Funding); ChemoCentryx – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); Galderma – Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);
Ruth Ann Vleugels, MPH, MD, MBA, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria); Astra Zeneca – Consultant (1099 relationship)(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria);